Skip to main content
Michigan OPEN

Updated Guidelines for Hepatitis C in Patients with Substance Use Disorder

Virtual
Jun 3, 2025

12-1PM

Click Here or Scan the QR Code to Register!

Join us for a webinar on the latest updates in hepatitis C (HCV) care for patients with substance use disorder (SUD). We will review new HCV guidelines, highlighting best practices for screening, diagnosis, and treatment in this population. The session will also explore strategies for improving access to care, addressing barriers, and integrating HCV management into substance use treatment.

Learning Objectives:

  • Review the updated clinical guidelines for managing hepatitis C in patients with substance use disorder and explore the unique challenges in providing integrated care for this population.
  • Examine evidence-based practices for the treatment of hepatitis C in patients with substance use disorder
  • Discuss the importance of a collaborative, multidisciplinary approach to care and the ethical considerations in treating individuals with both hepatitis C and substance use disorder.

1 CE Credit (1.0 hour):

  • CME
  • MCBAP
  • Social Work
  • Meets DEA Training Requirements

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MyMichigan Health and OPEN: Overdose Prevention Engagement Network. MyMichigan Health is accredited by the Michigan State Medical Society (MSMS) to provide continuing medical education for physicians. MyMichigan Health designates this live activity for a maximum of 1 AMA PRA Category Credit(s)TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement: Planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.

Presenter(s):

  • Ponni Perumalswami, MD, MSCR